Carlos Brites is an expert in Infectiology at Complexo Hospitalar Universitário Professor Edgard Santos (Brazil). As of October 2026, ScienceLeadR ranks Carlos Brites in the top 1% of experts worldwide for HIV Infections and Immunologic Deficiency Syndromes. Carlos Brites has authored 328 publications, the most recent in 2026, and is an investigator in 17 clinical trials, 6 of them ongoing. SLR score: 1,291 (community average: 125). How the SLR is computed.

LeadR Profile

1 291 ScienceLeadR Reputation 1291
Network Map

Infectiology

Subspecialties: Public Health - Immunology - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1992 - 2026

Source: PubMed

Federal University of Bahia

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 328

Citations

Citations: 8 339 1st author: 32 Last author: 123 Unique author: 5


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Development of a Single Thermal Cycling Multiplex RT-qPCR Assay for Rapid Arbovirus Detection.
PMID 42882360 — arboviruses, molecular biology, chikungunya virus, viruses
Diagnostics (Basel)20260
Benchmarking large language models for clinical data extraction from Portuguese medical notes in a university hospital.
PMID 42561294 — language, public health, cardiology, records, benchmarking, universities
Cad Saude Publica20262
Molecular Characterization of Hepatitis Delta Virus in the Western Amazon, Acre, Brazil.
PMID 42515582 — hepatitis d, phylogeography, virology, hepatitis delta virus, viruses, genotype, hepatitis
Viruses20260
PI3K gene variants are associated with elevated IL-6 levels and COVID-19 severe outcomes in a multicenter study.
PMID 42469329 — cells, genes, blood, interleukin-6, covid-19, alleles, genotype
Sci Rep20260
HHV-8 genotypes and clinical features in Kaposi sarcoma and primary effusion lymphoma in people living with HIV in Salvador, Brazil.
PMID 42404792 — sarcoma, kaposi, lymphoma, lymphoma, primary effusion, sarcoma, hiv, genotype, herpesvirus 8, human
Front Microbiol20260

Clinical Studies 17

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Chair: 1

By phase:

Phase 3 5
N/A 3
Phase 2 3
Phase 2/Phase 3 3
Phase 4 3

By status:

Completed 10
Recruiting 4
Active not recruiting 1
Not yet recruiting 1
Unknown 1

By type:

Interventional 15
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 2
multicentric5to9 3
multicentricup10 9

Main Topics

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Dolutegravir Lamivudine in Treatment Na ve Pregnant Women
NCT07616739 — pregnant women, hiv-1, pregnancy, safety, incidence, lamivudine, tablets, hiv, emtricitabine, therapeutics, infections, dolutegravir, women
Phase 4Not yet recruiting2026
Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV 1 Infection
NCT07555431 — cells, tenofovir, leukemia-lymphoma, adult t-cell, human t-lymphotropic virus 1, lymphoma, neuritis, leukemia, leukemia, t-cell, paraparesis, tropical spastic, therapeutics, htlv-i infections, t-lymphocytes, spinal cord diseases, infections, paraparesis, dolutegravir
Phase 2Recruiting2026
Dolutegravir Lamivudine Dual Therapy for ART na ve People With HIV and TB Receiving Rifampin based TB Treatment
NCT06497465 — tenofovir, lamivudine, tablets, fumarates, tuberculosis, therapeutics, rifampin, dolutegravir
Phase 3Recruiting2025
A Study of Propranolol to Treat Kaposi Sarcoma
NCT05797662 — sarcoma, kaposi, propranolol, suspensions, tablets, sarcoma, therapeutics, mouth, child
Phase 2Recruiting2026
Pre Exposure Prophylaxis Study of Lenacapavir in Cisgender Men Transgender Women Transgender Men and Gender Nonbinary People at Risk for HIV Infection
NCT04925752 — injections, emtricitabine, tenofovir disoproxil fumarate drug combination, tenofovir, safety, parturition, pre-exposure prophylaxis, pharmaceutical preparations, drug combinations, tablets, food, fumarates, emtricitabine, sex, hiv infections, infections, male, women
Phase 3Active not recruiting2021

LeadR Networks

Main global connection map